Mizuho Securities Reiterates Buy Rating on Fate Therapeutics (FATE) on Expanding Ono Collaboration
Go back to Mizuho Securities Reiterates Buy Rating on Fate Therapeutics (FATE) on Expanding Ono Collaboration| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 1.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.87 | 52 Week High | $4.76 | |||
| Open | $1.87 | 52 Week Low | $1.46 | |||
| Day High | $1.87 | P/E | N/A | |||
| Day Low | $1.87 | EPS | $-1.91 | |||
| Volume | 1,942 | |||||
